Modified Fraility Index in Patients Undergoing Arthroplasty
NCT ID: NCT05424575
Last Updated: 2022-06-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
145 participants
OBSERVATIONAL
2020-07-20
2021-01-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Frailty Index as An Indicator Associated With Postoperative Adverse Outcomes In The Older Population
NCT05742737
Predictive Ability of Different Frailty Indices for Postoperative Infections in Elderly Patients
NCT06985771
Assessment of Frailty as a Risk Factor for Cardiac and Vascular Surgery
NCT02224222
Association Between Frailty and Postoperative Adverse Outcomes in Patients Undergoing Urological Surgery
NCT05871879
Pre-frailty and Rehospitalization in Cardiac Surgery
NCT03949439
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
There are 11 parametres in Modified Fraility Index (MFI) (Exacerbation of chronic obstructive pulmonary disease or history of pneumonia (within last 30 days), exacerbation of congestive heart failure (within last 30 days), diabetes mellitus, dependant functional status (partially or totally dependant), history of angina, percutaneous coronary intervention or coronary bypass grefting) (within last 30 days), medically treated hypertension, acute impaired sensorium, history of peripheral vascular disease, history of myocardial infarction (within last 6 months), cerebrovascular disease with neurological deficit, cerebrovascular disease without neurological deficit or transient ischemic attack (TIA).
Presence of one of the above MFI parameters has taken 1 point. The total point that each individual achieved according to the presence of the parameters is calculated and the total score divided by 11 is defined as MFI value.
145 patients aged between 45-85 who had undergone primary or revision total knee and hip arthroplasty were included to the current prospective study. In all patients MFI was calculated.
Patients were classified as nonfrail (MFI\<0,27), and frail patients (MFI≥0.27) according to MFI value.
All patients were followed up for 30 days during postoperative period. The presence of myocardial infarction, cardiac arrest, pulmonary embolism, septic shock, postoperative dialysis requirement, cerebrovascular event, reintubation, reoperation, prolonged mechanical ventilation, surgical wound complications; duration of hospitalization; requirement for intensive care unit (ICU) admission and rehospitalization and 30th day mortality were questioned.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group Nonfrail (Group NF)
Modified fraility index was calculated in all patients. Modified fraility index \< 0.27 were included to Group NF.
No interventions assigned to this group
Group Frail (Group F)
Modified fraility index was calculated in all patients. Modified fraility index ≥ 0.27 were included to Group F.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
45 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ankara University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sanem Cakar Turhan
Assoc. Prof., MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sanem Cakar Turhan, Assoc. Prof.
Role: STUDY_CHAIR
Ankara University Medical School Department of Anesthesiology and ICU
Leyla Alıbaylı, Specialist
Role: PRINCIPAL_INVESTIGATOR
Ankara University Medical School Department of Anesthesiology and ICU
Volkan Baytas, Specialist
Role: PRINCIPAL_INVESTIGATOR
Ankara University Medical School Department of Anesthesiology and ICU
Suheyla Karadag Erkoc, Specialist
Role: PRINCIPAL_INVESTIGATOR
Ankara University Medical School Department of Anesthesiology and ICU
Onat Bermede, Specialist
Role: PRINCIPAL_INVESTIGATOR
Ankara University Medical School Department of Anesthesiology and ICU
Hakan Kocaoglu, Assoc. Prof.
Role: PRINCIPAL_INVESTIGATOR
Ankara University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ankara University Medical School Anesthesiology and ICU Department
Ankara, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Alibayli L, Cakar Turhan KS, Baytas V, Karadag Erkoc S, Bermede O, Kocaoglu H. Modified frailty index (mFI): is it a predictor for early postoperative complications in arthroplasty surgery? Eur Rev Med Pharmacol Sci. 2024 Feb;28(3):1002-1014. doi: 10.26355/eurrev_202402_35336.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AU I2-59-19
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.